190 related articles for article (PubMed ID: 36147656)
1. The Pathologic Complete Response Ratio of Liver Metastases Represents a Valuable Prognostic Indicator.
Xu Y; He J; Li W; Zhang W; Liu S; He J; Pan Z; Lu Z; Peng J; Lin J
Pathol Oncol Res; 2022; 28():1610663. PubMed ID: 36147656
[No Abstract] [Full Text] [Related]
2. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of conversion hepatectomy for initially unresectable colorectal liver metastasis.
Takamizawa Y; Inoue M; Moritani K; Tsukamoto S; Esaki M; Shimada K; Kanemitsu Y
Langenbecks Arch Surg; 2022 Nov; 407(7):2893-2903. PubMed ID: 36068379
[TBL] [Abstract][Full Text] [Related]
4. Pathologic response after preoperative therapy predicts prognosis of Chinese colorectal cancer patients with liver metastases.
Wang Y; Yuan YF; Lin HC; Li BK; Wang FH; Wang ZQ; Ding PR; Chen G; Wu XJ; Lu ZH; Pan ZZ; Wan DS; Sun P; Yan SM; Xu RH; Li YH
Chin J Cancer; 2017 Oct; 36(1):78. PubMed ID: 28969708
[TBL] [Abstract][Full Text] [Related]
5. Pre-hepatectomy dynamic circulating tumor DNA to predict pathologic response to preoperative chemotherapy and post-hepatectomy recurrence in patients with colorectal liver metastases.
Liu M; Bao Q; Zhao T; Huang L; Zhang D; Wang Y; Yan X; Wang H; Jin K; Liu W; Wang K; Xing B
Hepatol Int; 2024 Jun; 18(3):1029-1039. PubMed ID: 38427145
[TBL] [Abstract][Full Text] [Related]
6. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
[TBL] [Abstract][Full Text] [Related]
7. Preoperative CA19-9: a competitive predictor of recurrence in patients with colorectal cancer liver metastases after hepatectomy.
Liu JM; Wang YY; Liu W; Xu D; Wang K; Xing BC
Int J Colorectal Dis; 2021 Apr; 36(4):767-778. PubMed ID: 33420522
[TBL] [Abstract][Full Text] [Related]
8. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.
Gagnière J; Dupré A; Gholami SS; Pezet D; Boerner T; Gönen M; Kingham TP; Allen PJ; Balachandran VP; De Matteo RP; Drebin JA; Yaeger R; Kemeny NE; Jarnagin WR; D'Angelica MI
Ann Surg; 2020 Jan; 271(1):147-154. PubMed ID: 29995686
[TBL] [Abstract][Full Text] [Related]
9. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
[TBL] [Abstract][Full Text] [Related]
10. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
11. Efficacy of Adjuvant Chemotherapy Following Curative Resection of Colorectal Cancer Liver Metastases.
Takeda K; Kikuchi Y; Sawada YU; Kumamoto T; Watanabe J; Kuniski C; Misumi T; Endo I
Anticancer Res; 2022 Nov; 42(11):5497-5505. PubMed ID: 36288891
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection.
Liu YW; Lu CC; Chang CD; Lee KC; Chen HH; Yeh WS; Hu WH; Tsai KL; Yeh CH; Wee SY; Yin SM; Wang CC; Hung CH
Sci Rep; 2020 Apr; 10(1):6459. PubMed ID: 32296122
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of clinicopathological characteristics in early-onset versus late-onset colorectal cancer liver metastases.
Li YT; Wang XY; Zhang B; Tao BR; Chen ZM; Ma XC; Han JH; Zhang C; Zhang R; Chen JH
Int J Colorectal Dis; 2023 Jan; 38(1):19. PubMed ID: 36658235
[TBL] [Abstract][Full Text] [Related]
14. Impact of Metformin Use on Survival in Patients Undergoing Liver Resection for Colorectal Cancer Metastases.
Kaltenmeier C; Morocco B; Yazdani H; Reitz K; Meyer K; Molinari M; Geller D; Tohme S
Am Surg; 2021 Nov; 87(11):1766-1774. PubMed ID: 34766506
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Perioperative Red Blood Cell Transfusions on Long-Term Outcomes after Hepatectomy for Colorectal Liver Metastases.
Hallet J; Tsang M; Cheng ES; Habashi R; Kulyk I; Hanna SS; Coburn NG; Lin Y; Law CH; Karanicolas PJ
Ann Surg Oncol; 2015 Nov; 22(12):4038-45. PubMed ID: 25752895
[TBL] [Abstract][Full Text] [Related]
17. Effect of tumour size ratio on liver recurrence-free survival of patients undergoing hepatic resection for colorectal liver metastases.
Zhai Y; Bai W; Zhou J; Dong Q; Zhang J
BMC Cancer; 2022 Jan; 22(1):103. PubMed ID: 35078439
[TBL] [Abstract][Full Text] [Related]
18. The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
Margonis GA; Buettner S; Andreatos N; Wagner D; Sasaki K; Galjart B; Kamphues C; Pawlik TM; Poultsides G; Kaczirek K; Lønning PE; Verhoef C; Kreis ME; Wolfgang CL; Weiss MJ
J Surg Oncol; 2018 Dec; 118(7):1074-1080. PubMed ID: 30261094
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of different parenchymal-sparing hepatectomies in patients with colorectal liver metastases and prognostic impact of peritumoral imaging features.
Liu L; Xie L; Zhou Y; Li Q; Lei X; Tang H; Wu J; Zhao X; Yang P; Mao Y
Abdom Radiol (NY); 2023 Dec; 48(12):3728-3745. PubMed ID: 37750923
[TBL] [Abstract][Full Text] [Related]
20. Fibrosis-4 Index, a Noninvasive Fibrosis Marker, Predicts Survival Outcomes After Hepatectomy for Colorectal Cancer Liver Metastases.
Akiyama T; Miyamoto Y; Imai K; Yamashita Y; Nomoto D; Daitoku N; Sakamoto Y; Kiyozumi Y; Tokunaga R; Eto K; Harada K; Hiyoshi Y; Iwatsuki M; Nagai Y; Iwagami S; Baba Y; Yoshida N; Baba H
Ann Surg Oncol; 2020 Sep; 27(9):3534-3541. PubMed ID: 32648180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
